Leukotriene B4 is a physiologically relevant endogenous peroxisome proliferator-activated receptor-alpha agonist.
Peroxisome proliferator-activated receptors (PPARs) are nuclear transcription factors that play central roles in metabolism and inflammation. Although a variety of compounds have been shown to activate PPARs, identification of physiologically relevant ligands has proven difficult. In silico studies of lipid derivatives reported here identify specific 5-lipoxygenase products as candidate physiologically relevant PPAR-alpha activators. Subsequent studies show both in vitro and in a murine model of inflammation that 5-lipoxygenase stimulation induces PPAR-alpha signaling and that this results specifically from production of the inflammatory mediator and chemoattractant leukotriene B(4) (LTB(4)). Activation of PPAR-alpha is a direct effect of intracellularly generated LTB(4) binding to the nuclear receptor and not of secreted LTB(4) acting via its cell-surface receptors. Activation of PPAR-alpha reduces secretion of LTB(4) by stimulating degradation of this fatty acid derivative. We also show that the LTB(4) precursors leukotriene A(4) (LTA(4)) and 5-hydroperoxyeicosatetrenoic acid (5-HPETE) activate PPAR-alpha but have no significant endogenous effect independent of conversion to LTB(4). We conclude that LTB(4) is a physiologically relevant PPAR-alpha activator in cells of the immune system. This, together with previous findings, demonstrates that different types of lipids serve as endogenous PPAR-alpha ligands, with the relevant ligand varying between functionally different cell types. Our results also support the suggestion that regulation of inflammation may involve balancing proinflammatory effects of LTB(4), exerted through cell-surface receptors, and anti-inflammatory effects exerted through PPAR-alpha activation.
Narala
Venkata R
VR
Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109-2200, USA.
Adapala
Ravi K
RK
Suresh
Madathilparambil V
MV
Brock
Thomas G
TG
Peters-Golden
Marc
M
Reddy
Raju C
RC
D000596:Amino Acids / Q000378:metabolism; D000818:Animals; D001094:Arachidonate 5-Lipoxygenase / Q000378:metabolism; D002460:Cell Line; D019295:Computational Biology; D006801:Humans; D007975:Leukotriene B4 / Q000096:biosynthesis / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D008024:Ligands; D051379:Mice; D008958:Models, Molecular; D047493:PPAR alpha / Q000819:agonists* / Q000737:chemistry / Q000378:metabolism
D000596:Amino Acids; D008024:Ligands; D047493:PPAR alpha; D007975:Leukotriene B4; D001094:Arachidonate 5-Lipoxygenase
J Biol Chem. 2002 Jun 28;277(26):23278-86
11956198
Structure. 2001 Aug;9(8):699-706
11587644
J Exp Med. 2003 Aug 4;198(3):411-21
12900517
Int J Biochem Cell Biol. 1998 Feb;30(2):173-8
9608670
J Pharmacol Exp Ther. 2001 Nov;299(2):691-7
11602682
J Biol Chem. 2004 Aug 20;279(34):36093-102
15190061
Drug Metab Dispos. 2007 Jul;35(7):1126-34
17431031
Biochemistry. 1999 Jan 5;38(1):185-90
9890897
Nature. 1996 Nov 7;384(6604):39-43
8900274
J Clin Invest. 2003 Sep;112(6):945-55
12975479
Cell. 2009 Aug 7;138(3):476-88
19646743
J Biol Chem. 1998 Dec 4;273(49):32833-41
9830030
Eur J Biochem. 1992 Oct 1;209(1):281-9
1327771
Mol Endocrinol. 1997 Jun;11(6):779-91
9171241
J Biol Chem. 2006 Mar 17;281(11):7189-96
16380383
N Engl J Med. 2007 Nov 1;357(18):1841-54
17978293
Biochem Biophys Res Commun. 2000 Dec 20;279(2):520-5
11118319
Biochem Biophys Res Commun. 1981 Apr 30;99(4):1230-7
6266415
Biochemistry. 1991 Sep 24;30(38):9346-54
1654095
Circulation. 2007 Jan 30;115(4):518-33
17261671
Arch Biochem Biophys. 2007 May 1;461(1):104-12
17418803
Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4312-7
9113986
Biochim Biophys Acta. 2007 Aug;1771(8):915-25
17317294
J Biomed Biotechnol. 2004;2004(3):156-166
15292582
J Biol Chem. 2000 Sep 15;275(37):28918-28
10844002
Cell. 1995 Dec 1;83(5):803-12
8521497
Eur J Pharmacol. 2004 Sep 19;499(1-2):53-65
15363951
Biochem J. 2007 Aug 1;405(3):379-95
17623009